These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 34157302)

  • 21. A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.
    Du X; Tang F; Liu M; Su J; Zhang Y; Wu W; Devenport M; Lazarski CA; Zhang P; Wang X; Ye P; Wang C; Hwang E; Zhu T; Xu T; Zheng P; Liu Y
    Cell Res; 2018 Apr; 28(4):416-432. PubMed ID: 29472691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remodeling of the tumor microenvironment via disrupting Blimp1
    Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
    Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology.
    Sansom DM; Walker LS
    Immunol Rev; 2006 Aug; 212():131-48. PubMed ID: 16903911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
    Knitz MW; Bickett TE; Darragh LB; Oweida AJ; Bhatia S; Van Court B; Bhuvane S; Piper M; Gadwa J; Mueller AC; Nguyen D; Nangia V; Osborne DG; Bai X; Ferrara SE; Boss MK; Goodspeed A; Burchill MA; Tamburini BAJ; Chan ED; Pickering CR; Clambey ET; Karam SD
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33883256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTLA-4 blockade drives loss of T
    Zappasodi R; Serganova I; Cohen IJ; Maeda M; Shindo M; Senbabaoglu Y; Watson MJ; Leftin A; Maniyar R; Verma S; Lubin M; Ko M; Mane MM; Zhong H; Liu C; Ghosh A; Abu-Akeel M; Ackerstaff E; Koutcher JA; Ho PC; Delgoffe GM; Blasberg R; Wolchok JD; Merghoub T
    Nature; 2021 Mar; 591(7851):652-658. PubMed ID: 33588426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.
    Sun NY; Chen YL; Lin HW; Chiang YC; Chang CF; Tai YJ; Chen CA; Sun WZ; Chien CL; Cheng WF
    Cancer Lett; 2019 Mar; 444():20-34. PubMed ID: 30543813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducing CTLA-4-dependent immune regulation by selective CD28 blockade promotes regulatory T cells in organ transplantation.
    Poirier N; Azimzadeh AM; Zhang T; Dilek N; Mary C; Nguyen B; Tillou X; Wu G; Reneaudin K; Hervouet J; Martinet B; Coulon F; Allain-Launay E; Karam G; Soulillou JP; Pierson RN; Blancho G; Vanhove B
    Sci Transl Med; 2010 Feb; 2(17):17ra10. PubMed ID: 20371478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-faceted inhibition of dendritic cell function by CD4
    Seitz C; Liu S; Klocke K; Joly AL; Czarnewski PV; Tibbitt CA; Parigi SM; Westerberg LS; Coquet JM; Villablanca EJ; Wing K; Andersson J
    J Autoimmun; 2019 Mar; 98():86-94. PubMed ID: 30616979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory T cells impede acute and long-term immunity to blood-stage malaria through CTLA-4.
    Kurup SP; Obeng-Adjei N; Anthony SM; Traore B; Doumbo OK; Butler NS; Crompton PD; Harty JT
    Nat Med; 2017 Oct; 23(10):1220-1225. PubMed ID: 28892065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring CTLA-4-Dependent Suppressive Function in Regulatory T Cells.
    Hou TZ; Qureshi OS; Sansom DM
    Methods Mol Biol; 2019; 1899():87-101. PubMed ID: 30649767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells.
    Stojanovic A; Fiegler N; Brunner-Weinzierl M; Cerwenka A
    J Immunol; 2014 May; 192(9):4184-91. PubMed ID: 24688023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Id1 expression promotes T regulatory cell differentiation by facilitating TCR costimulation.
    Liu C; Wang HC; Yu S; Jin R; Tang H; Liu YF; Ge Q; Sun XH; Zhang Y
    J Immunol; 2014 Jul; 193(2):663-672. PubMed ID: 24920844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
    Kondo Y; Ohno T; Nishii N; Harada K; Yagita H; Azuma M
    Oral Oncol; 2016 Jun; 57():54-60. PubMed ID: 27208845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4.
    Halliday N; Williams C; Kennedy A; Waters E; Pesenacker AM; Soskic B; Hinze C; Hou TZ; Rowshanravan B; Janman D; Walker LSK; Sansom DM
    Front Immunol; 2020; 11():600000. PubMed ID: 33363541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.
    Sojka DK; Hughson A; Fowell DJ
    Eur J Immunol; 2009 Jun; 39(6):1544-51. PubMed ID: 19462377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity.
    Vogel I; Kasran A; Cremer J; Kim YJ; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2015 Jun; 45(6):1832-41. PubMed ID: 25727069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.
    Wing K; Yamaguchi T; Sakaguchi S
    Trends Immunol; 2011 Sep; 32(9):428-33. PubMed ID: 21723783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells.
    Sun B; Liu M; Cui M; Li T
    Immunol Lett; 2020 Jan; 217():7-14. PubMed ID: 31669380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.